Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia.
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
J Adolesc Health. 2022 Jul;71(1):86-93. doi: 10.1016/j.jadohealth.2022.01.229. Epub 2022 Mar 26.
In 2013, age restrictions for adolescents on over-the-counter access were removed for "Plan B One-Step", a single oral medication option for emergency contraception use. Restrictions on generic options of the emergency contraceptive pill (ECP) were removed in 2014.
National Survey of Family Growth data were used to assess the prevalence of ever use of ECPs among sexually experienced female adolescents and young adults (AYA) aged 15-24 years (2015-2017 sample), and trends in indicators of ECP use and acquisition (2006-2017 samples). Prevalence estimates were obtained by age subgroups for 15-17, 18-19, and 20-24 years. Statistical significance was determined using an alpha of .05 and 95% confidence intervals calculated around the point estimates.
The weighted estimate of sexually experienced female AYA in the United States ranged from 13.3 million in 2006-2008 to 12.7 million in 2015-2017. The prevalence of ever ECP use was 18.2% (95% CI 15.7-21.1) and 31.8% (95% CI 26.9-37.1) in 2006-2008 and 2015-2017, respectively. Ever use in 2015-2017 varied by age group, number of lifetime opposite-sex partners and abortions, and experience of nonconsensual sex. In 2008-2010, 46.1% (95% CI 36.0-56.5) of respondents last obtained ECPs at community health or family planning clinics, and 31.8% (95% CI 22.9-42.2) last obtained ECPs at a pharmacy compared to 18.1% (95% CI 12.0-26.4) and 70.1% (95% CI 60.6-78.1) respectively in 2015-2017. Prevalence of provider counseling about emergency contraception in female AYA regardless of prior sexual experience in the past 12 months remained at or below 5% from 2006 to 2017.
Increasing access to ECPs over-the-counter may have contributed to notable increases in reported ever use of ECPs and in the receipts from a pharmacy among AYA between 2006 and 2017. AYA may benefit if pharmacists and healthcare providers increase reproductive health counseling.
2013 年,“Plan B One-Step”(一种紧急避孕的单一口服药物选择)对青少年的非处方获取年龄限制被取消。2014 年取消了紧急避孕药(ECP)的通用选项的限制。
使用全国家庭增长调查数据评估了在过去的 12 个月中,有过性行为的 15-24 岁的青少年和年轻成年人(2015-2017 年样本)使用 ECP 的流行率,以及 ECP 使用和获取的指标趋势(2006-2017 年样本)。对于 15-17、18-19 和 20-24 岁的年龄组,获得了流行率估计值。使用 0.05 的α值确定统计学意义,并围绕点估计值计算 95%置信区间。
美国有过性行为的青少年和年轻女性的加权估计数在 2006-2008 年期间为 1330 万,在 2015-2017 年期间为 1270 万。2006-2008 年和 2015-2017 年期间,ECP 的使用频率分别为 18.2%(95%CI 15.7-21.1)和 31.8%(95%CI 26.9-37.1)。在 2015-2017 年期间,年龄组、终生异性伴侣数量和堕胎数量以及非自愿性行为的经历均有所不同。在 2008-2010 年期间,46.1%(95%CI 36.0-56.5)的受访者最后在社区卫生或计划生育诊所获得 ECP,而 31.8%(95%CI 22.9-42.2)的受访者最后在药店获得 ECP,而 2015-2017 年期间分别为 18.1%(95%CI 12.0-26.4)和 70.1%(95%CI 60.6-78.1)。无论在过去 12 个月中是否有过性行为,在 2006 年至 2017 年期间,向青少年提供紧急避孕咨询的提供者的比例始终保持在 5%或以下。
非处方获得 ECP 的机会增加可能导致报告的过去 12 个月内青少年和年轻成年人使用 ECP 的比例以及从 2006 年至 2017 年期间从药店获得 ECP 的比例显著增加。如果药剂师和医疗保健提供者增加生殖健康咨询,青少年和年轻成年人可能会受益。